SMTL ID : 5uru.1 (1 other biounit)

Insulin with proline analog DhP at position B28 in the R6 state

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.41 Å

Oligo State

hetero-6-6-mer

Ligands

6 x IPH: PHENOL(Non-covalent)

IPH.1: 7 residues within 4Å: Chain A: C.6, S.9, I.10, C.11 Chain B: H.10, L.11 Chain F: H.5 4 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B, 1 interactions with chain F Hydrogen bonds: A:C.11, A:C.11 Hydrophobic interactions: B:L.11 pi-Cation interactions: F:H.5 IPH.4: 8 residues within 4Å: Chain C: C.6, S.9, I.10, C.11, L.16 Chain D: H.10, L.11 Chain L: H.5 6 PLIP interactions: 2 interactions with chain D, 3 interactions with chain C, 1 interactions with chain L Hydrophobic interactions: D:H.10, D:L.11, C:L.16 Hydrogen bonds: C:C.6, C:C.11 pi-Stacking: L:H.5 IPH.7: 7 residues within 4Å: Chain E: C.6, S.9, I.10, C.11 Chain F: H.10, L.11 Chain J: H.5 4 PLIP interactions: 1 interactions with chain F, 2 interactions with chain E, 1 interactions with chain J Hydrophobic interactions: F:L.11 Hydrogen bonds: E:C.11, E:C.11 pi-Cation interactions: J:H.5 IPH.10: 8 residues within 4Å: Chain D: H.5 Chain G: C.6, S.9, I.10, C.11, L.16 Chain H: H.10, L.11 6 PLIP interactions: 2 interactions with chain H, 3 interactions with chain G, 1 interactions with chain D Hydrophobic interactions: H:H.10, H:L.11, G:L.16 Hydrogen bonds: G:C.6, G:C.11 pi-Stacking: D:H.5 IPH.13: 7 residues within 4Å: Chain B: H.5 Chain I: C.6, S.9, I.10, C.11 Chain J: H.10, L.11 4 PLIP interactions: 1 interactions with chain B, 1 interactions with chain J, 2 interactions with chain I pi-Cation interactions: B:H.5 Hydrophobic interactions: J:L.11 Hydrogen bonds: I:C.11, I:C.11 IPH.16: 8 residues within 4Å: Chain H: H.5 Chain K: C.6, S.9, I.10, C.11, L.16 Chain L: H.10, L.11 6 PLIP interactions: 2 interactions with chain L, 3 interactions with chain K, 1 interactions with chain H Hydrophobic interactions: L:H.10, L:L.11, K:L.16 Hydrogen bonds: K:C.6, K:C.11 pi-Stacking: H:H.5

6 x ZN: ZINC ION(Non-covalent)

ZN.2: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: CL.3, ZN.8, CL.9, ZN.14, CL.15 3 PLIP interactions: 1 interactions with chain F, 1 interactions with chain B, 1 interactions with chain J Metal complexes: F:H.10, B:H.10, J:H.10 ZN.5: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: CL.6, ZN.11, CL.12, ZN.17, CL.18 3 PLIP interactions: 1 interactions with chain H, 1 interactions with chain D, 1 interactions with chain L Metal complexes: H:H.10, D:H.10, L:H.10 ZN.8: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.2, CL.3, CL.9, ZN.14, CL.15 3 PLIP interactions: 1 interactions with chain F, 1 interactions with chain B, 1 interactions with chain J Metal complexes: F:H.10, B:H.10, J:H.10 ZN.11: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.5, CL.6, CL.12, ZN.17, CL.18 3 PLIP interactions: 1 interactions with chain H, 1 interactions with chain D, 1 interactions with chain L Metal complexes: H:H.10, D:H.10, L:H.10 ZN.14: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.2, CL.3, ZN.8, CL.9, CL.15 3 PLIP interactions: 1 interactions with chain F, 1 interactions with chain B, 1 interactions with chain J Metal complexes: F:H.10, B:H.10, J:H.10 ZN.17: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.5, CL.6, ZN.11, CL.12, CL.18 3 PLIP interactions: 1 interactions with chain D, 1 interactions with chain H, 1 interactions with chain L Metal complexes: D:H.10, H:H.10, L:H.10

6 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 11 residues within 4Å: Chain B: L.6, H.10 Chain F: L.6, H.10 Chain J: L.6, H.10 Ligands: ZN.2, ZN.8, CL.9, ZN.14, CL.15 Ligand excluded by PLIP CL.6: 11 residues within 4Å: Chain D: L.6, H.10 Chain H: L.6, H.10 Chain L: L.6, H.10 Ligands: ZN.5, ZN.11, CL.12, ZN.17, CL.18 Ligand excluded by PLIP CL.9: 11 residues within 4Å: Chain B: L.6, H.10 Chain F: L.6, H.10 Chain J: L.6, H.10 Ligands: ZN.2, CL.3, ZN.8, ZN.14, CL.15 Ligand excluded by PLIP CL.12: 11 residues within 4Å: Chain D: L.6, H.10 Chain H: L.6, H.10 Chain L: L.6, H.10 Ligands: ZN.5, CL.6, ZN.11, ZN.17, CL.18 Ligand excluded by PLIP CL.15: 11 residues within 4Å: Chain B: L.6, H.10 Chain F: L.6, H.10 Chain J: L.6, H.10 Ligands: ZN.2, CL.3, ZN.8, CL.9, ZN.14 Ligand excluded by PLIP CL.18: 11 residues within 4Å: Chain D: L.6, H.10 Chain H: L.6, H.10 Chain L: L.6, H.10 Ligands: ZN.5, CL.6, ZN.11, CL.12, ZN.17 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lieblich, S.A. et al., Insulin with proline analog DhP at position B28 in the R6 state. To Be Published

Release Date

2018-02-21

Peptides

Insulin Chain A: ACEGIK
Insulin Chain B: BDFHJL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

E
A

G
C

I
A

K
C

B
B

D
D

F
B

H
D

J
B

L
D

Insulin Chain A

Insulin Chain B

Related Entries With Identical Sequence